BioSpace News Archive

In a release issued earlier today by Agile Therapeutics, Inc. (Nasdaq: AGRX), please note the headline should read “Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2021" instead of “Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2020". The corrected release follows: Agile Therapeutics to Report First Quarter 2021

More than a year into the coronavirus pandemic, there remains a disregard of proven science when it comes to how people, especially large groups in public spaces, are being screened for fever, the leading symptom of COVID-19.

BD (Becton, Dickinson and Company), a leading global medical technology company, is voluntarily recalling specified lots of the ChloraPrep™ Hi-Lite Orange™ 26 mL Applicator (2% w/w chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA)) to the user level due to a defective applicator.

Cognition Therapeutics, Inc. , a clinical stage neuroscience company developing drugs that treat degenerative disorders by regulating cellular damage response pathways, announced that the board of directors has elected Jack A. Khattar chairman of the board. Mr. Khattar, the founder and CEO of Supernus Pharmaceuticals, was appointed in 2020 to serve as a member of the Cognition board of directors. He replaces former chairman, Robert J. Gailus, w

Kendra Scott announced a new partnership with Diligent Robotics - a female-founded A.I. company creating robot assistants that help healthcare workers - on its Kendra Cares program.

MJH Life Sciences™, the privately-owned health care media company, is excited to officially announce that it has expanded its Strategic Alliance Partnership (SAP) program with the addition of the Global Liver Institute (GLI), a collaborative and innovative platform for the entire spectrum of liver diseases and liver health advocates.

EMA Confirms Overall Benefit-Risk Profile Remains Positive Company to update the COVID-19 Vaccine Janssen Summary of Product Characteristics and Package Leaflet to include important information on very rare adverse event

Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that its management team will participate at the following upcoming investor conferences: Attend investor meetings at the Truist Securities 7th Annual Life Sciences Summit on Tuesday, May 4, 2021.

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the first quarter ended March 31, 2021, after the market close, and host a conference call at 4:30pm Eastern Time on Wednesday, April 28. Wednesday April 28th @ 4:30pm ET

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2021 after market close on Tuesday, May 4, 2021.